These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 8009254

  • 1. Intravenous pamidronate: evolution of an effective treatment strategy.
    Anderson DC, Richardson PC, Brown JK, Freemont AJ, Hollis S, Denton J, Buckler HM, Hargreaves S, Cantrill JA.
    Semin Arthritis Rheum; 1994 Feb; 23(4):273-5. PubMed ID: 8009254
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Long-term efficacy of intravenous pamidronate in Paget's disease of bone.
    Grauer A, Klar B, Scharla SH, Zieglar R.
    Semin Arthritis Rheum; 1994 Feb; 23(4):283-4. PubMed ID: 8009261
    [No Abstract] [Full Text] [Related]

  • 4. Intravenous aminopropylidene bisphosphonate in the treatment of severe polyostotic Paget's disease of bone.
    Fritz P, Lioté F, Kuntz D.
    Semin Arthritis Rheum; 1994 Feb; 23(4):282. PubMed ID: 8009260
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Bone scintigraphy following intravenous pamidronate for Paget's disease of bone.
    Ryan PJ, Gibson T, Fogelman I.
    J Nucl Med; 1992 Sep; 33(9):1589-93. PubMed ID: 1517830
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Paget's disease and its therapeutic management].
    Orcel P, Rousière M.
    Presse Med; 2005 Apr 23; 34(8):612-6. PubMed ID: 15962504
    [Abstract] [Full Text] [Related]

  • 13. [Therapy of Paget's disease with bisphosphonate pamidronate (AHPrBP, formerly APD)].
    Scharla SH, Grauer A, Ziegler R.
    Klin Wochenschr; 1991 Jan 04; 69(1):25-30. PubMed ID: 2016845
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical and biological effects of low doses of (3 amino-1 hydroxypropylidene)-1,1-bisphosphonate (APD) in Paget's disease of bone.
    Heynen G, Delwaide P, Bijvoet OL, Franchimont P.
    Eur J Clin Invest; 1982 Feb 04; 12(1):29-35. PubMed ID: 6802650
    [No Abstract] [Full Text] [Related]

  • 17. Effects of intravenous pamidronate therapy on Paget's disease of bone.
    Bombassei GJ, Yocono M, Raisz LG.
    Am J Med Sci; 1994 Oct 04; 308(4):226-33. PubMed ID: 7942981
    [Abstract] [Full Text] [Related]

  • 18. Pamidronate sodium and calcitonin-resistant Paget's disease. Immediate response in a patient.
    Drake S, Massie JD, Postlethwaite AE, Palmieri GM.
    Arch Intern Med; 1989 Feb 04; 149(2):401-3. PubMed ID: 2783843
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.